Semi-Annual Statement Of Income

Noile-Immune Biotech Inc. - Filing #7312147

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Semi-annual statement of income
Statement of income
Ordinary profit (loss)
-682,206,000 JPY
-832,341,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
40,159,000 JPY
35,072,000 JPY
Operating profit (loss)
-681,816,000 JPY
-481,500,000 JPY
Profit (loss) before income taxes
-682,206,000 JPY
-832,341,000 JPY
Income taxes - current
1,214,000 JPY
1,213,000 JPY
Non-operating income
80,000 JPY
22,000 JPY
Non-operating income
Interest income
28,000 JPY
22,000 JPY
Income taxes
1,214,000 JPY
1,213,000 JPY
Non-operating expenses
470,000 JPY
350,863,000 JPY
Profit (loss)
-683,420,000 JPY
-833,554,000 JPY
Non-operating expenses

Talk to a Data Expert

Have a question? We'll get back to you promptly.